NanGenex
NanGenex is a privately held Hungarian company formed in 2006 by Dr. Ferenc Darvas as a spin-off company of ThalesNano. The company provides breakthrough virtual high throughput nanoparticle formulation technology solutions to develop new generations of organic NanoActive products with significant performance benefits over conventional approaches for the pharmaceutical, agrochemical, cosmetic, food, nutraceuticals and home care industries.
The Company's core technologies and expertise span the full R&D and commercialization value chain from upstream research and discovery to full scale product manufacturing and commercialization. NanGenex has also developed a portfolio of proprietary NanoActiveTM drugs of block-buster active pharmaceutical ingredients (APIs). These nano-drugs have undergone extensive validation and shown significant benefits over the parent active molecules.
